Reece Marillier

Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy

Bruno Gomes, Grégory Driessens, Derek W. Bartlett et al. · Molecular Cancer Therapeutics · 2018 · 83 citations · Full text

IL-4/IL-13 independent goblet cell hyperplasia in experimental helminth infections

Reece Marillier, Chesney Michels, Elizabeth M. Smith et al. · BMC Immunology · 2008 · 66 citations · Full text

Restoration of T-cell Effector Function, Depletion of Tregs, and Direct Killing of Tumor Cells: The Multiple Mechanisms of Action of a-TIGIT Antagonist Antibodies

Julie Preillon, Julia Cuende, Virginie Rabolli et al. · Molecular Cancer Therapeutics · 2020 · 63 citations · Full text

IL-4Rα-Independent Expression of Mannose Receptor and Ym1 by Macrophages Depends on their IL-10 Responsiveness

Benjamin G Dewals, Reece Marillier, J. Claire Hoving et al. · PLoS neglected tropical diseases · 2010 · 50 citations · Full text

Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression

Ludovic Belle, Kimberle A. Agle, Vivian Zhou et al. · Blood · 2016 · 41 citations · Full text